(Q37067709)

18 August 2017

Potency and mass of factor VIII in FVIII products (English)

1 reference

18 August 2017

4

E D Gomperts

1 reference

18 August 2017

S Butenas

1

1 reference

18 August 2017

B Parhami-Seren

2

1 reference

18 August 2017

M T Gissel

3

1 reference

18 August 2017

D N Fass

5

1 reference

18 August 2017

K G Mann

6

1 reference

18 August 2017

6 August 2008

1 reference

18 August 2017

1 reference

18 August 2017

15

1 reference

18 August 2017

1

1 reference

18 August 2017

63-72

1 reference

First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely?

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Assaying the circulating factor VIII activity in hemophilia A patients treated with recombinant factor VIII products

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Measurement of factor VIII activity of B-domain deleted recombinant factor VIII.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Factor IX concentrates for clinical use.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Isolation of functional human coagulation factor V by using a hybridoma antibody

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

The size of human factor VIII heterodimers and the effects produced by thrombin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

A concentrate of human antihaemophilic factor; its use in six cases of haemophilia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

A model for the stoichiometric regulation of blood coagulation.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Influence of phospholipids on the assessment of factor VIII activity

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

In vivo recovery with products of very high purity--assay discrepancies

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Blood coagulation in hemophilia A and hemophilia C.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Treatment of Hemophilia B with a New Clotting-Factor Concentrate

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628971

Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer

4 September 2018

1 reference

12 December 2020

The role of phospholipid and factor VIIIa in the activation of bovine factor X

1 reference

12 December 2020

A Simplified Procedure for Purification of Human Prothrombin, Factor IX and Factor X

1 reference

12 December 2020

The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles

1 reference

12 December 2020

Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid

1 reference

12 December 2020

Reactive site peptide structural similarity between heparin cofactor II and antithrombin III

1 reference

12 December 2020

Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII

1 reference

12 December 2020

Genetic basis of hemophilia A

1 reference

12 December 2020

A model for the tissue factor pathway to thrombin. I. An empirical study

1 reference

12 December 2020

Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V

1 reference

12 December 2020

Blood clotting in minimally altered whole blood

1 reference

12 December 2020

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II

1 reference

12 December 2020

Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases

1 reference

12 December 2020

Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X

1 reference

12 December 2020

10.1111/J.1365-2516.2008.01826.X

Identifiers

DOI

1 reference

release_yqm7yxp6ozbrbe7pcvnpayebei

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqm7yxp6ozbrbe7pcvnpayebei

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

PubMed publication ID

18691375

1 reference